Pacific Biosciences of California, Inc.
PACB
$1.13
$0.043.67%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 103.90% | 64.96% | -121.70% | 4.68% | -22.65% |
| Total Depreciation and Amortization | -31.99% | 12.67% | 18.94% | 2.69% | 114.46% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -418.53% | -85.21% | 601.81% | -22.78% | 132.20% |
| Change in Net Operating Assets | 148.45% | -172.84% | 75.03% | -227.49% | 38.55% |
| Cash from Operations | 32.58% | 16.22% | 28.30% | -31.48% | 11.69% |
| Capital Expenditure | -305.46% | 153.21% | 61.87% | -91.65% | -143.86% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 168.67% | -71.55% | 358.84% | 53.13% | -126.54% |
| Cash from Investing | 152.50% | -69.98% | 325.09% | 48.73% | -127.47% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | 55.03% | 24.04% | 8.44% |
| Issuance of Common Stock | -100.00% | -- | -100.00% | 636.22% | -79.48% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -1,590.20% |
| Cash from Financing | -6,282.27% | 634.21% | -102.32% | 108.03% | -10,348.40% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.75% | -196.27% | 121.71% | 49.81% | -216.66% |